124 related articles for article (PubMed ID: 9652441)
1. Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators.
Tzianabos AO; Gibson FC; Cisneros RL; Kasper DL
J Infect Dis; 1998 Jul; 178(1):200-6. PubMed ID: 9652441
[TBL] [Abstract][Full Text] [Related]
2. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB
J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
[TBL] [Abstract][Full Text] [Related]
3. Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity.
Kalka-Moll WM; Tzianabos AO; Wang Y; Carey VJ; Finberg RW; Onderdonk AB; Kasper DL
J Immunol; 2000 Jan; 164(2):719-24. PubMed ID: 10623815
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism.
Chung DR; Kasper DL; Panzo RJ; Chitnis T; Grusby MJ; Sayegh MH; Tzianabos AO
J Immunol; 2003 Feb; 170(4):1958-63. PubMed ID: 12574364
[TBL] [Abstract][Full Text] [Related]
5. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
Onderdonk AB; Shapiro ME; Finberg RW; Zaleznik DF; Kasper DL
Rev Infect Dis; 1984; 6 Suppl 1():S91-5. PubMed ID: 6372042
[TBL] [Abstract][Full Text] [Related]
6. Good and laudable pus.
Gorbach SL
J Clin Invest; 1995 Dec; 96(6):2545. PubMed ID: 8675616
[No Abstract] [Full Text] [Related]
7. Prevention of intraperitoneal adhesion formation using beta-glucan after ileocolic anastomosis in a rat bacterial peritonitis model.
Bedirli A; Gokahmetoglu S; Sakrak O; Ersoz N; Ayangil D; Esin H
Am J Surg; 2003 Apr; 185(4):339-43. PubMed ID: 12657386
[TBL] [Abstract][Full Text] [Related]
8. IL-2 mediates protection against abscess formation in an experimental model of sepsis.
Tzianabos AO; Russell PR; Onderdonk AB; Gibson FC; Cywes C; Chan M; Finberg RW; Kasper DL
J Immunol; 1999 Jul; 163(2):893-7. PubMed ID: 10395684
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses.
Tzianabos AO; Kasper DL; Onderdonk AB
Clin Infect Dis; 1995 Jun; 20 Suppl 2():S132-40. PubMed ID: 7548535
[TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
[TBL] [Abstract][Full Text] [Related]
11. Passive transfer of poly-(1-6)-beta-glucotriosyl-(1-3)-beta-glucopyranose glucan protection against lethal infection in an animal model of intra-abdominal sepsis.
Cisneros RL; Gibson FC; Tzianabos AO
Infect Immun; 1996 Jun; 64(6):2201-5. PubMed ID: 8675327
[TBL] [Abstract][Full Text] [Related]
12. Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation.
Tzianabos AO; Onderdonk AB; Zaleznik DF; Smith RS; Kasper DL
Infect Immun; 1994 Nov; 62(11):4881-6. PubMed ID: 7927768
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis with the immunomodulator PGG glucan enhances antibiotic efficacy in rats infected with antibiotic-resistant bacteria.
Tzianabos AO; Cisneros RL
Ann N Y Acad Sci; 1996 Oct; 797():285-7. PubMed ID: 8993382
[TBL] [Abstract][Full Text] [Related]
14. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
[TBL] [Abstract][Full Text] [Related]
15. Bacterial structure and functional relation to abscess formation.
Tzianabos AO; Onderdonk AB; Kasper DL
Infect Agents Dis; 1994 Oct; 3(5):256-65. PubMed ID: 7866658
[TBL] [Abstract][Full Text] [Related]
16. Zwitterionic polysaccharides stimulate T cells with no preferential V beta usage and promote anergy, resulting in protection against experimental abscess formation.
Stingele F; Corthésy B; Kusy N; Porcelli SA; Kasper DL; Tzianabos AO
J Immunol; 2004 Feb; 172(3):1483-90. PubMed ID: 14734725
[TBL] [Abstract][Full Text] [Related]
17. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
Kasper DL; Onderdonk AB
Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
[TBL] [Abstract][Full Text] [Related]
18. Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis.
Gibson FC; Onderdonk AB; Kasper DL; Tzianabos AO
J Immunol; 1998 May; 160(10):5000-6. PubMed ID: 9590249
[TBL] [Abstract][Full Text] [Related]
19. Cellular immunity to Bacteroides fragilis capsular polysaccharide.
Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
J Exp Med; 1982 Apr; 155(4):1188-97. PubMed ID: 6174672
[TBL] [Abstract][Full Text] [Related]
20. Surface antigens as virulence factors in infection with Bacteroides fragilis.
Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
